title: Cytosine arabinoside and amphotericin B-induced parkinsonism.
authors.forename: K
authors.initials: K
authors.lastname: Kulkantrakorn
authors.forename: J B
authors.initials: JB
authors.lastname: Selhorst
authors.forename: P J
authors.initials: PJ
authors.lastname: Petruska
mesh_terms: D000666:Amphotericin B / Q000009:adverse effects* / Q000627:therapeutic use; D002230:Carbidopa / Q000627:therapeutic use; D003561:Cytarabine / Q000009:adverse effects* / Q000627:therapeutic use; D004305:Dose-Response Relationship, Drug; D005260:Female; D006801:Humans; D015479:Leukemia, Myelomonocytic, Acute / Q000188:drug therapy*; D007980:Levodopa / Q000627:therapeutic use; D008171:Lung Diseases / Q000188:drug therapy*; D008875:Middle Aged; D010302:Parkinson Disease, Secondary / Q000139:chemically induced* / Q000188:drug therapy
chemical_list: D003561:Cytarabine; D007980:Levodopa; D000666:Amphotericin B; D002230:Carbidopa